Primary adenocarcinoma of the appendix: Experience at La Paz University Hospital of Madrid (1967–2014)  by León Arellano, Miguel et al.
Research Paper
Primary adenocarcinoma of the appendix: Experience at La Paz
University Hospital of Madrid (1967–2014)
Miguel León Arellano a, Yannko González-Domínguez a, Fernando Molina-Ortiz b,
María Alexandra Heras Garceau a, Ramón Cantero a, José Antonio Rodríguez-Montes a,*
a Department of General and Digestive Surgery, “La Paz” University Hospital, Madrid, Spain
b Department of Pathology, “La Paz” University Hospital, Madrid, Spain
A R T I C L E I N F O
Article history:
Received 22 July 2015
Accepted 20 June 2016
Available online 27 June 2016
A B S T R A C T
Background: Primary adenocarcinoma of the appendix (PAA) is a rare tumor, and it represents 0.03%
of all appendiceal pathology. Diagnosis is made during histopathological study in patients with acute
appendicitis.
Objective: This study aimed to present our experience in this pathology.
Methods and Materials: Retrospective study of all patients with acute appendicitis (AA) at University
Hospital La Paz of Madrid, during 47 years (1967–2014). We studied age, gender, preoperative diag-
nose, surgery, histopathology, evolution and survival rate.
Results: There were 44 patients with mean age 60.3 years (32–91) with PAA; 25 (47%) were male. The
most common preoperative diagnosis was AA in 29 cases (66%), followed by right lower quadrant plas-
tron in 12 cases (27%). AA coexisted in 12 cases (27%). The ﬁrst surgery was an appendectomy in 32 patients
(73%) and right colectomy in 12 (27%). In 32 patients who had an appendectomy, a right colectomy was
done between 2 and 5 weeks after ﬁrst surgery. 30 cases (68%) were well differentiated mucosecretor
adenocarcinoma. In 37 cases, tumoral invasion affected serous layer without lymph node affection. 12-
year survival rate was 59%. Mean follow up time was 8.2 years (4 months–32 years).
Conclusions: PAA is a rare tumor, and in our series it represented 0.01% of 53,019 appendectomies. Pre-
operative diagnosis was unusual. Clinical presentation was similar to appendicitis. Elective treatment was
right colectomy.
© 2016 Published by Elsevier Ltd on behalf of Surgical Associates Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Primary adenocarcinoma of the vermiform appendix are rare
tumors and are frequently diagnosed incidentally at histologic as-
sessment of the surgical specimen following appendectomy for
suspected or diagnosed appendicitis. Neoplasms of the appendix
are found in 1% of all appendectomies specimens with a frequen-
cy of adenocarcinoma of 0,1% [1]. The incidence of this kind of
neoplasm varies from 0,01 to 0,2 per 100.000 persons per year [2]
and it constitutes less than 0,5% of all gastrointestinal malignant
neoplasms [3,4].
The aim of this paper is to present our experience of adenocar-
cinoma of appendix at La Paz University Hospital of Madrid.
2. Materials and methods
This study involved a retrospective study of all primary adeno-
carcinomas of appendix at La Paz University Hospital, since January
1967 to December 2014 (47 years). There were no exclusive crite-
ria. Diagnosis of adenocarcinoma was made by a thorough study
of the surgical specimens, with identiﬁcation of surgical proximal
circumferential edge, inﬁltration level and involvement of surgi-
cal margins.
Tumor staging was performed according to the classiﬁcation of
Dukes–Astler and Coller; parietal inﬁltration and lymph node me-
tastasis level were prognostic factors. This classiﬁcation also applies
to colorectal cancer. We followedWolff–Ahmed’s [5] criteria to de-
termine if the origin of the tumor was from the appendix or an
inﬁltration from a cecal neoplasm. The inﬁltration of the appen-
dix wall was made by complete mapping of the surgical specimen,
from intramucosal, submucosa, muscle itself, subserous, serous in-
ﬁltration tomesoappendix. The base of the appendix was considered
as proximal third, and the end as distal; the identiﬁed lesions were
adscript to their respective third; in those cases where the lesion
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was between two thirds, we reviewed the photographic archives
to specify the exactly location.
We analyze survival time as a variable given in months, as well
as age, gender, localization, tumor size, histologic type, grade of dif-
ferentiation, inﬁltration level and the evolution time. We considered
alive the dead patients in whom the appendiceal cancer wasn’t the
cause of death. Statistical study was made by Kaplan–Meyer sur-
vival rate.
3. Results
During 47 years, there were 53,019 appendectomies performed
in our center. Histopathological diagnosis revealed the presence of
44 (0.01%) primary appendiceal adenocarcinomas; a further anal-
ysis of the results revealed that 25 cases (57%) were men and 19
(43%) were women. The average age was 60.3 years (32–91 years;
SD: 15.04 years). Themost common preoperative diagnosis was acute
appendicitis in 29 cases (66%), followed by plastron/right inferior
quadrant tumor in 12 cases (27%) and appendiceal mucocele in 3
cases (7%). Past medical history and complementary analysis in-
cluded CBC, thorax and abdominal X-rays, and abdominal CT which
was not always performed.
A simple appendectomy was performed in 32 cases (73%) and
it was followed by right colectomy between 2 and 5 weeks and in
one case in 12 weeks; a primary right colectomy was performed
in 12 cases (27%).
Histopathological analysis revealed that the tumor was present
at the middle and distal third of the appendix in 32 cases (73%).
The macroscopic analysis showed parietal thickening areas with de-
creased luminal caliber; microscopically the description were: well
differentiated muco-secretors adenocarcinomas with a glandular
papillary pattern (68%), except in 2 cases (5%), and morphology seal
rings in the remaining 12 (27%). In 37 cases (84%) the tumor inﬁl-
trated the muscular and serous layers, without lymph node
involvement (stage Dukes B2–Astler and Coller).
In 4 cases (12.5%) residual tumor or lymph nodemetastases were
observed in colectomy parts corresponding to the 32 cases (73%)
within initial appendectomy. Coexisting acute appendicitis was veri-
ﬁed in 12 cases (27%), parietal drilling in 11 (25%) and appendiceal
mucocele in 7 (16%) of the operated patients who had a primary
adenocarcinoma of the appendix. Tumor size was less than 1 cm
in 7 cases (16%), between 1 and 2 cm in 31 cases (70%) and more
than 2 cm in 6 cases (14%).
Two patients died in the immediate postoperative period with
pulmonary embolism (65 and 91 years old) and 11 died in the period
from 4 months to 5.3 years after deﬁnitive surgery.
Among postoperative complications there were 2 patients who
presented surgical site infection (4.5%); 3 bowel obstruction; 2 acute
renal failure; 2 pneumonia; 1 abdominal abscess; and 3 wound de-
hiscence (6.8%). Two patients received only palliative treatment for
peritoneal carcinomatosis; none survived more than four months.
Other 4 patients with Dukes C–Astler–Coller received postopera-
tive 5-FU. Global morbidity rate was 27%.
During follow up we observed that there were 3 patients who
developed rectal cancer. They were treated with a low anterior re-
section, radiotherapy and chemotherapy; one of them also developed
liver and pulmonary metastases at 9 and 16 months from rectal re-
section, and he died 4 years after colectomy. One patient had a
hysterectomy, oophorectomy and rectal resection for a “pelvic mass”
2 years after colectomy.
Another patient had a bowel resection for an adenocarcinoma
recurrence 3 years since colectomy and died 2 years after. One patient
was diagnosed with non-Hodkin’s lymphoma 3 years after colec-
tomy, and he is alive after 8 years. Mean follow up timewas 8.2 years
(4 months to 32 years). Overall survival was 86%, 75% and 59.2% for
1, 5 and 12 years.
4. Discussion
Primary appendiceal adenocarcinoma is a raremalignancywith
0,12 cases per million diagnosed annually [6,7]. The condition was
ﬁrst describedbyBerger in 1882 [8]. Appendix carcinomas areusually
classiﬁed according to histopathological examination into four dis-
tinct subtypes with varying frequencies: cystic, colonic, carcinoid,
and adenocarcinoid [1,9–11]. Macroscopically there are four forms:
ulcerate, vegetative, inﬁltrative or mixed. Carcinoid subtype is the
most common, comprisingnearly90%of all primaryappendix tumors.
Mucinous cystoadenocarcinoma is the second most common
subtype. Colonic subtype has a 0,082% frequency. The cystic subtype
is similar to ovarian adenocarcinoma, thus rupture and dissemina-
tion is possible. It has better survival rates compared to colonic
subtype.
The colonic subtype originates from a villous or tubular-villous
adenoma and it appears as an ulcerated or polypoid tumor [12].
Primary appendiceal cancer is diagnosed in 0,9% to 1,4% of all ap-
pendectomy specimens [13].
Acute appendicitis and pelvic or ovarian tumors still are the most
common clinical presentation of appendiceal adenocarcinoma
[14–18], but rarer presentations include urinary frequency mim-
icking bladder cancer [19–21], hydronephrosis [22], mimicking
Crohn’s disease [23], cecal intussusception [24], anemia [25] and
Krukenberg tumor of the ovary [26]. In our series 12 patients (27%)
presented with acute appendicitis and 19 patients with a palpa-
ble right lower quadrant mass, which represents 27% of our patients.
Mean age of presentation was in the ﬁfth or sixth decades and sex
distribution was equal [27].
Preoperative diagnosis of primary appendiceal carcinoma is in-
variably diﬃcult since the clinical presentation is usually nonspeciﬁc
[15]. Therefore, appendiceal carcinoma is always neglected or mis-
diagnosed [21]. The diagnosis of primary appendiceal carcinoma
usually depends on the histopathological analysis following ap-
pendectomy or other explorative surgical procedures [27].
Nevertheless, these tumors are seldom suspected before surgery,
and less than one-half are diagnosed during surgery [28–30]. Re-
cently, procedures such as intestinal endoscopy, barium enema, and
selective ileocolic arteriography have been used for the preopera-
tive diagnosis of carcinoma of the appendix; however, non-
established method currently exists.
In accordance with the other published studies [16,21,31], ap-
pendiceal neoplasm was established preoperatively in none of our
cases. Some authors recommend suspecting the possibility of pre-
senting adenocarcinoma in elderly patients with appendicitis that
present inﬂammatory plastron, lymphadenopathy, or non-
inﬂammatory tissue [32].
One of the most common features of primary adenocarcinoma
of the appendix is the tendency to be perforated [15], which occurs
in 11 (25%) of our patients (pseudomyxoma is assumed to be a per-
forated state), and which requires distinguishing the perforation
location [11].
The reasons for high incidence of perforation have been attrib-
uted to (1) thin muscularis layer in this region of gastrointestinal
tract; (2) terminal arterial supply, as opposed to branching arcades
of the intestine, and (3) small appendiceal lumen, making it easy
to perforate by tumor growth and copious mucinous secretion [33].
Pseudomyxoma peritoneal originates from mucinous appendi-
ceal adenocarcinoma and is characterized by mucinous ascites.
Initially, neoplasm obstructs appendiceal lumen; subsequently, ap-
pendiceal perforation causes tumor cells to spread into the whole
peritoneal cavity. Patients with this condition die frommassive tumor
load, terminal starvation, or surgical complication from repeated
debulking surgery [34].
The signiﬁcance of tumor histological type remains controver-
sial. The data presented in the literature concerning the prognosis
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according to the different histological subtypes are not yet conclu-
sive. McCuster et al. [6] found that 56% of tumors were classiﬁed
as mucinous appendix carcinoma, 37,6% to the colonic subtype and
6,4% to ring cell subtype. The ﬁve year survival rate for all patients
was 54,4% and was associated with the stage of disease, the grading
and the histological subtype; the same authors reported 5-year sur-
vival rates of 44% for tumor with mucinous subtype, 52% for the
colonic subtype and 20% for the signet ring cell subtype. Nitecki et al.
[29] found a survival rate of 100% for patients with tumors classi-
ﬁed as Dukes A, 67% for Dukes B, 50% for Dukes C and 6% for Dukes
D carcinomas. Other authors reported that the mucinous histolo-
gy is the best prognostic factor [7,35], but another study done by
Ito et al. [27] claims that mucinous-type adenocarcinoma has poorer
outcome. Another study showed no survival difference between
colonic-type andmucinous type groups [15]. However, all these anal-
ysis share the same problem of small patient numbers so a large
multicenter study is still needed for elucidation. The general prog-
nosis seems to be close to that reported for colonic cancer [1,6,27,29].
Preferred surgical treatment is still controversial. While simple
appendectomy seems to be suﬃcient for early, non-invasive carci-
nomas of the appendix [36], most tumors usually present as
advanced invasive carcinomas and a secondary right colectomy is
recommended as the treatment of choice [35] between the second
and fourth week after appendectomy [12].
Appendectomy is appropriate for the small tumor (pT1), usually
found incidentally, measuring less than 2 cm and lacking mesoap-
pendiceal involvement [15]. On the other hand, several clinical
studies have demonstrated better survival rate after right colec-
tomy compared to only appendectomy [14,17]. For primary
appendiceal tumors greater than 2 cm, involving mesoappendix or
base of the appendix, a right colectomy should be considered [36,37].
That is because colonic-type adenocarcinoma can metastasize
through lymphatic drainage and a formal right colectomy will solve
this problem. For mucinous-type adenocarcinoma with
pseudomyxoma peritonei, a right colectomy is the preferred pro-
cedure [29].
In our opinion, the criteria of making only appendectomies when
there is an “A” stage of Dukes–Astler and Coller [32,38] is not an
oncological correct resection, due to the fact that survival rate is
higher when a right colectomy is done [17,32], and also because there
is a high rate of appendiceal tumoral rests in the colectomy pieces
[39]; this happened in 12.5% of our patients. The only situation that
appendectomy alone is justiﬁed is when the tumor is a villous
adenoma appendix limited to mucosa and does not exceed mus-
cularis mucosae and has no vascular inﬁltration [40,41].
Adjuvant chemotherapy in adenocarcinoma of appendix is not
yet established in clinical practice; therefore it is recommended for
patients with positive lymph node affection or locally advanced
tumors to be treated in accordance with the recommendation for
colon cancer. Postoperative adjuvant chemotherapy for stage IV pa-
tients shows no survival beneﬁts [20]. However, carcinomas of the
appendix frequently shows local inﬁltration in the surrounding peri-
toneum with increased risk of locoregional recurrence; for these
patients with peritoneal tumor inﬁltration or peritoneal metasta-
sis cytoreductive surgery in combination with hyperthermic
chemotherapy might be an additional therapeutic option [1]. Ra-
diotherapy could decrease the risk of peritoneal local recurrence,
in the perforated cases [11], although the results are still poor [5].
Mucinous-type appendiceal adenocarcinoma with
pseudomyxoma is a special disease entity. The diffusely scattered
tumor cells in the peritoneal cavity usually stay in the peritoneal
surface and grow slowly. In the early years, surgeons tried to combat
this disease with repeated debulking surgery and intravenous che-
motherapy but the results were discouraging [22,42]. In the last years
Sugarbaker has developed a deﬁnitive cytoreductive surgery with
hyperthermic intraoperative intraperitoneal chemotherapywith good
results [43]. Nowadays, this concept has become accepted as a fea-
sible option. With conventional debulking surgery, over-all ﬁve year
survival rates is about 30–50% [20]; however, when cytoreductive
surgery and hyperthermia intraoperative intraperitoneal chemo-
therapy is performed, ﬁve year survival rate can be improved to 52–
96% according to other authors [42–44]. From the surgical point of
view with curative intent, the data of Chen et al. [16] also support
that as long as the tumor can be resected radically, there will be
survival advantage. To treat primary adenocarcinoma of the ap-
pendix many medical institutions around the world are practicing
the procedure proposed by Sugarbaker team but many of these
centers fail to replicate the safety and survival beneﬁts shown during
their initial experience. Clearly, numerous years of experience is re-
quired to overcome the initial learning curve before surgeons can
appropriately select patients for treatment, perform the proce-
dure safely, and manage the postoperative complications wisely.
The investigation of biological alterations of appendiceal carci-
noma have so far reported classic mutations associatedwith sporadic
colorectal cancer including frequent K-ras mutations and rare p53
protein overexpression, and all tumors investigated so far were
microsatellite stable [45]. Therefore, the mucinous appendix car-
cinomawith high grademicrosatellite, ﬁrst described by Komm et al.
[1], seems to represent a distinct tumor etiology and might de-
scribe a yet unidentiﬁed alteration in the DNA repair pathway with
possible implications for chemotherapeutic modiﬁcations during ad-
juvant chemotherapy [1].
5. Conclusions
Primary adenocarcinoma of the appendix is a rare tumor, rep-
resenting 0.01% of 53,019 appendectomies in our series. Clinical
presentation is quite similar to acute appendicitis. Preoperative di-
agnosis is diﬃcult, although it may be suspected in some cases.
Elective treatment, once diagnosis is made, is right colectomy.
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